Searchable abstracts of presentations at key conferences in endocrinology

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0089c40 | Clinical – Surgery/Applied Pathology | NANETS2022

TP53 Mutation Portends a Worse Overall Survival in Patients with Advanced Grade 3 Well-Differentiated Neuroendocrine Tumors

Joseph Nancy , Paciorek Alan , Khuong Le Bryan , Moon Farhana , Zhang Li , Bergsland Emily

Background: The well-differentiated grade 3 neuroendocrine tumor (G3NET) category was introduced in the 2017 WHO classification as a new category of high-grade neuroendocrine neoplasm (NEN). G3NET is thought to have worse overall survival (OS) than lower grade NET, but better OS than poorly differentiated neuroendocrine carcinoma (NEC). However, challenges in pathologic diagnosis and changes in terminology have limited our understanding of the G3NET category. We compared outco...

ea0089p7 | Population Science | NANETS2022

Feasibility of e-NET: A Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors

Mulvey Claire K. , Steiding Paige , Moon Farhana , Paciorek Alan , Zhang Li , Bergsland Emily K.

Background: Patients with neuroendocrine neoplasms (NENs) have chronic symptoms from hormone overproduction, tumor growth and metastasis, and side effects from prolonged treatment. We assessed the feasibility of using a digital health platform to recruit patients with NENs to evaluate symptoms and quality of life.Methods: eNET is a prospective, web-based, cohort study for patients with advanced NENs of any primary site, histologic grade, differentiation,...

ea0090ep602 | Endocrine-related Cancer | ECE2023

Revision of the histopathological examination following 68 Ga DOTA-FAPI-04 PET/CT of a Neuroendocrine breast tumor diagnosed as Invasive Ductal Carcinomatosis initially

Sonmez Omer , Akcay Kaan , Beydağı Gamze , Alan Selcuk Nalan , Hacıhasanoğlu Ezgi

Neuroendocrine tumors (NETs) of the breast are very rare. They represent less than 1% of breast carcinomas. It is important to differentiate metastatic neuroendocrine neoplasia from primary neuroendocrine neoplasia of the breast. Histopathological misinterpretation of a breast NET is common. In a study of 18 NET cases that metastasized to the breast, it was found that 62% of these tumors originated from the gastrointestinal tract and 28% from the lung. Forty-four percent of th...

ea0091cb41 | Additional Cases | SFEEU2023

Oncocytic Adrenocortical Carcinoma - a rare variant

Poe Poe Han Htwe Nang , Abbas Afroze , Fraser Sheila , Anthoney Alan

A 59-year-old male patient, who is fit and well, presented with abdominal discomfort, night sweats, back pain and lower urinary tract symptoms. The CT scan, organised by the GP, demonstrated a 17 cm heterogenous mass with central necrosis and scattered calcification in right side of abdomen, possibly right adrenal origin or liver or kidney. He was referred to Adrenal MDT. Baseline functional testing showed unsuppressed cortisol level in an overnight dexamethasone, high DHEA su...

ea0063p48 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Pharmacokinetic Interaction Study of the Effects of Multiple-dose Gastric Acid Reducers Omeprazole (OMP) and Famotidine (FAM on the Pharmacokinetics (PK) of Single-dose Telotristat Etiprate (TE) in Healthy Subjects

Wilson Alan , Qubeck Christine , Warner Chris , Tesfaye Eshetu , Nguyen Quyen , Wason Suman

Background: TE is indicated for the treatment of carcinoid syndrome diarrhea in patients with metastatic neuroendocrine tumors.Objective: To evaluate the effects of a proton pump inhibitor (OMP) and H2 antagonist (FAM) on the PK of TE and its active metabolite LP-778902 via an open-label study of OMP (40 mg orally QD × 4 days) or FAM (40 mg orally BID × 4 days) with a single 250 mg oral dose of TE. Eligible subjects: healthy, nonsmoking, aged &...

ea0049ep1190 | Steroid metabolism + action | ECE2017

Homo-dimerisation of cytochrome P450c17 resolves the conundrum of the dual activities of cytochrome P450c17

Holien Jessica , Parker Michael , Conley Alan , Corbin C Jo , Rodgers Raymond , Martin Lisandra

Reproduction requires the temporal and spacial control of specific and exact signals, delivered by locally regulated hormonal flux. In the case of androgen biosynthesis, cytochrome P450 17α-hydroxylase, 17,20-lyase (P450c17) is the key enzyme. However, P450c17 is a multi-functional P450, so, it synthesizes cortisol in the zona fascicula of the adrenal cortex and also androgen precursors in the adrenal zona reticularis and the gonads. The regulation of this dual activity h...

ea0044p65 | Clinical biochemistry | SFEBES2016

Osteoporosis and low-dose prednisolone: Is there a link? Insights from bone turnover markers

Ang Yvette , Leckey Adam , Choudhury Sirazum , Courtney Alan , Tan Tricia , Meeran Karim

Prednisolone has been reported to have greater deleterious effects on bone turnover than other glucocorticoids, although the evidence for this is confounded by the effects of higher dose prednisolone, as used in conditions such as asthma. We hypothesise that a physiological replacement dose of prednisolone will have a less dramatic effect on bone than has previously been suggested, and might be safer than hydrocortisone for replacement in adrenal insufficiency. We investigated...

ea0044ep26 | (1) | SFEBES2016

Osteocalcin suppression may be a useful marker of steroid exposure

Ang Yvette , Leckey Adam , Choudhury Sirazum , Courtney Alan , Tan Tricia , Meeran Karim

Mrs. M is a 66-year-old female who has had secondary adrenal insufficiency for many years following the withdrawal of prednisolone therapy for pulmonary eosinophilia. Synacthen tests revealed complete adrenal suppression when the dose of prednisolone was weaned to 5 mg in previous years. The dose was further reduced by switching to hydrocortisone three times daily, following a 10 mg-5 mg-5 mg regimen. Occasionally, a flare of eosinophilia required restarting high-dose predniso...

ea0039oc7.4 | Oral Communications 7 | BSPED2015

The cost-effectiveness of the KIds in control of food structured education programme for adolescents with type 1 diabetes

Basirir Hasan , Brennan Alan , Jacques Richard , Pollard Daniel , Stevens Katherine , Freeman Jennifer , Wales Jeremy , Price Katherine

Objectives: Kids in control of food (KICK-OFF) is a 5-day structured education programme for 11–16 year olds with type 1 diabetes who use multiple daily insulin injections. This study evaluates whether KICk-OFF would be considered a cost effective use of NHS resources by decision makers in the UK.Methods: A cost effectiveness analysis comparing KICk-OFF to usual care was conducted. Data from the KICk-OFF trial were extrapolated to simulate lifetime ...